News - Cell Therapeutics, tosedostat


Popular Filters

US FDA puts partial clinical hold on Cell Thera's blood cancer drug tosedostat trial


US biotech firm Cell Therapeutics (Nasdaq: CTIC) revealed this week in a filing with the Securities Exchange…

BiotechnologyCell TherapeuticsNorth AmericaOncologyRegulationResearchtosedostat

Cell Therapeutics prepares for Pixuvri launch; posts 2nd-qtr results


US biotech firm Cell Therapeutics (Nasdaq: CTIC) yesterday reported second-quarter 2012 financial results…

BiotechnologyCell TherapeuticsFinancialMarkets & MarketingOncologypacritinibPixuvriRare diseasesResearchtosedostat

Back to top